Department of Medicine
Faculty Profiles by Division

Division of Gastroenterology, Hepatology and Nutrition

Faculty Profiles

[Return To Index page]
photo Naudia L. Jonassaint, MD, MHS, MBA


Interim Chief, Division of Gastroenterology, Hepatology and Nutrition

Associate Dean for Clinical Affairs, School of Medicine

Vice Chair, Diversity, Equity, and Inclusion, Department of Medicine

Associate Professor of Medicine


Phone: 412-647-5734

Office: Division of Gastroenterology, Hepatology and Nutrition - Center for Liver Diseases
3471 Fifth Avenue - 900 Kaufmann Building
Pittsburgh, 15213
Phone: 412-647-5734
Fax: 412-647-5070
Administrative Assistant:
Melissa Connell
Address: UPMC- Montefiore Hospital Transplant Hepatology
N758 Montefiore
Pittsburgh, PA 15213
Phone: 412-647-5734
Fax: 412-647-5070
Education and Training
MHS - Clinical Investigation, Johns Hopkins Bloomberg School of Public Health - Baltimore, MD, 2011
MD, Yale School of Medicine - New Haven, CT, 2005
BA - Biology, Johns Hopkins University - Baltimore, MD, 1999
MBA, Katz School of Business, University of Pittsburgh, 2021
Transplant Hepatology Fellowship, Johns Hopkins Hospital - Baltimore, MD, 2014
Gastroenterology & Hepatology Fellowship, Johns Hopkins Hospital - Baltimore, MD, 2013
Residency, Johns Hopkins Hospital - Baltimore, MD, 2008
Research Interest
Dr. Jonassaint is an Associate Professor of Medicine, and her research interests are focused on exploration of specific biologic markers involved in the development and progression of liver disease in both the pre- and post-transplant populations. Dr. Jonassaint is especially interested in disparities in liver transplant outcomes. Her research also explores why some patients experience rapid fibrosis progression or accelerated graft loss post-transplant.
Clinical Interest
Hepatology care for patients with liver diseases. Transplant Hepatologist.
Selected Publications:
Jonaissant N, Guo N, Califano JA, Montgomery EA, Armanios M. The Gastrointestinal Manifestations of Telomere-mediated Disease. Aging Cell. 2013; 12(2): 319-23.
Jakhete N, Saberi B, Jonassaint NL, Cosar AM, Luu H, Kim A, Ander RA, Philosophe B, Cameron AM, Gurakar A. Microvascular Invasion in Hepatocellular Carcinoma and Liver Transplant. Experimental Clinical Transplantation. 2016; 14(Suppl 3): 14-18.
Rogal SS, Mankaney G, Udawatta V, Chinman M, Good CB, Zickmund S, Bielefeldt K, Chidi A, Jonassaint N, Jazwinski A, Shaikh O, Hughes C, Fontes P, Humar A, Dimartini A. Pre-transplant Depression is Associated with Length of Hospitalization, Discharge Disposition, and Survival After Liver Transplantation. PLoS One. 2016; 11(11).
Rogal SS, McCarthy R, Reid A, Rodriguez KL, Calgaro L, Patel K, Daley M, Jonassaint NL, Zickmund SL. Primary Care and Hepatology Provider-perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence. Digestive Diseases and Sciences. 2017; 62(8): 1933-43.
Molinari M, Sood P, Samra PB, Tevar A, Ganoza A, Jonassaint N, Puttarajappa C. Atrial Fibrillation in Renal or Liver Transplant Recipients: A Systematic Review and Meta-analysis. Transplantation Review. 2018; 2018 Aug 9.
Molinari M, Ayloo S, Samra PB, Jonassaint N. Adult African Americans Undergoing Cadaveric Liver Trasnplantation for Hepatocellular carcinoma Within the Milan Criteria Have the Lowest 5-year Survival Among All the Ethnic Groups in the United States: Analysis of USA National Data Between January 2002 and June 2013. Hepatoma Research. 2018; 4: 56.
Molinari M, Ayloo S, Tsung A, Jorgensen D, Tevar A, Rahman SH, Jonassaint N. Prediction of Perioperative Mortality of Cadaveric Liver Transplant Recipients During Their Evaluations. Transplantation. 2019; June 24.
Moghe A, Klinge M, Jonassaint N. PRO: This Patient Should have a Liver Biopsy. Clinical Liver Diseases. 2019; 14(3) - Review: 112-15.
Molinari M, Jorgensen D, Ayloo S, Dharmayan S, Kaltenmeier C, Mehta R, Jonassaint N, Preoperative Stratification of Liver transplant Recipients: Validation of the LTRS. Transplantation. 2020; July 13.
Moghe A, Ganesh S, Humar A, Molinari M, Jonaissant N. Expanding Donor Selection and Recipient Indications for Living Donor Liver Transplantation. Clinical Liver Diseases. 2020.
Sponsored Research/Activities
Title: Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies (Collaborative U01)
Role: Co-Investigator
Funding Agency: National Institute on Alcohol Abuse & Alcoholism
Grant Number: U01 AA026978
Start Year: 2018
End Year: 2023
Notable Achievements
Member, American Society for Gastrointestinal Endoscopy, 2008 - Present
Member, American Gastroenterological Association, 2008 - Present
Member, American Association for the Study of Liver Diseases, 2008 - Present